In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.
The in vitro activities of three newly developed quinolone drugs (T-3262, NY-198, and fleroxacin [AM-833; RO 23-6240]) against 10 strains of clinically isolated Chlamydia trachomatis were assessed and compared with those of other quinolones and minocycline. T-3262 (MIC for 90% of isolates tested, 0....
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
1988
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172348/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2847640/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.7.1080 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|